These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Phosphorylcholine acts as a Ca2+-dependent receptor molecule for lymphocyte perforin. Tschopp J; Schäfer S; Masson D; Peitsch MC; Heusser C Nature; 1989 Jan; 337(6204):272-4. PubMed ID: 2783478 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes. Berke G; Rosen D; Ronen D Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395 [TBL] [Abstract][Full Text] [Related]
25. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. Berke G; Rosen D J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. Lancki DW; Hsieh CS; Fitch FW J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149 [TBL] [Abstract][Full Text] [Related]
27. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets. Bajpai A; Kwon BS; Brahmi Z Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042 [TBL] [Abstract][Full Text] [Related]
28. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin. Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109 [TBL] [Abstract][Full Text] [Related]
29. A new model for lethal hit delivery by cytotoxic T lymphocytes. Peters PJ; Geuze HJ; van der Donk HA; Borst J Immunol Today; 1990 Jan; 11(1):28-32. PubMed ID: 2405876 [TBL] [Abstract][Full Text] [Related]
31. Cellular localization of perforin 1 in murine cloned cytotoxic T lymphocytes. Groscurth P; Qiao BY; Podack ER; Hengartner H J Immunol; 1987 May; 138(9):2749-52. PubMed ID: 3494768 [TBL] [Abstract][Full Text] [Related]
32. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin. Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821 [TBL] [Abstract][Full Text] [Related]
33. A calcium- and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes. Young JD; Clark WR; Liu CC; Cohn ZA J Exp Med; 1987 Dec; 166(6):1894-9. PubMed ID: 3500267 [TBL] [Abstract][Full Text] [Related]
34. Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells. Persechini PM; Young JD; Almers W J Cell Biol; 1990 Jun; 110(6):2109-16. PubMed ID: 1693622 [TBL] [Abstract][Full Text] [Related]
35. Resistance of normal, unstimulated, CD8+ T cells to lysis by cytotoxic granules from cloned T cell lines. Nagler-Anderson C; Eisen HN Int Immunol; 1990; 2(1):99-103. PubMed ID: 2150923 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of the lytic activity of perforin by lipoproteins. Tschopp J; Masson D; Schäfer S J Immunol; 1986 Sep; 137(6):1950-3. PubMed ID: 2427587 [TBL] [Abstract][Full Text] [Related]
37. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. Müller C; Tschopp J J Immunol; 1994 Sep; 153(6):2470-8. PubMed ID: 7521362 [TBL] [Abstract][Full Text] [Related]
38. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes. Young JD; Liu CC; Persechini PM; Cohn ZA Immunol Rev; 1988 Mar; 103():161-202. PubMed ID: 3292393 [TBL] [Abstract][Full Text] [Related]
39. Arrest of the cell cycle reduces susceptibility of target cells to perforin-mediated lysis. De Leon M; Jackson KM; Cavanaugh JR; Mbangkollo D; Verret CR J Cell Biochem; 1998 Jun; 69(4):425-35. PubMed ID: 9620169 [TBL] [Abstract][Full Text] [Related]
40. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity. Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]